date,title,source
Oct-23-18,"Investor Expectations to Drive Momentum within Navios Maritime Partners LP, Alliance Data, Eli Lilly, CONVERGEONE HLD, Atkore International Group, and NantKwest  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-23-18,NantKwest Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-07-18,"NantKwest Announces Promising First in Human Clinical Results of 300 Doses Of CD16 Targeted, Off-The-Shelf Cryopreserved Natural Killer Cells (haNK) in a Novel Cancer Memory Vaccine Immunotherapy",Business Wire
Nov-08-18,Here's Why NantKwest Skyrocketed 26.4% Today,Motley Fool
Nov-08-18,"Healthcare Stocks are Gaining Ground in Technology Niche: Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Inovalon Holdings, NantKwest Inc.",ACCESSWIRE
Dec-03-18,NantKwest to Present Updated Preclinical Data at the 60th Annual Meeting of the American Society of Hematology,Business Wire
Dec-18-18,Is Nantkwest Inc (NK) Going to Burn These Hedge Funds?,Insider Monkey
Dec-25-18,"Have Insiders Been Selling NantKwest, Inc. (NASDAQ:NK) Shares?",Simply Wall St.
Jan-07-19,Soon-Shiongs NantCell gets $30 million from Celgene,American City Business Journals
Jan-09-19,NantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple Combination of off-the-Shelf Natural Killer haNK Cell Therapy with Superagonist IL-15 Cytokine Therapy and PD-L1 Checkpoint Inhibitor Therapy,Business Wire
